|
Volumn 6, Issue 4, 2002, Pages 349-356
|
Quality of life effects of antithrombin III in sepsis survivors: Results from the KyberSept trial [ISRCTN22931023]
|
Author keywords
Antithrombin III; Clinical trial; Quality of life; Sepsis
|
Indexed keywords
ANTITHROMBIN III;
HEPARIN;
KYBERNIN P;
LOW MOLECULAR WEIGHT HEPARIN;
PLACEBO;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DATA ANALYSIS;
DISEASE SEVERITY;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
FEMALE;
FOLLOW UP;
HEALTH STATUS;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
PATIENT CARE;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
PROGNOSIS;
PSYCHOLOGICAL ASPECT;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
RANK SUM TEST;
SEPSIS;
SOCIAL ASPECT;
SOCIAL STATUS;
SURVIVAL;
VISUAL ANALOG SCALE;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTITHROMBIN III;
APACHE;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
MULTICENTER STUDIES;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIALS;
SEPSIS;
SERINE PROTEINASE INHIBITORS;
TREATMENT OUTCOME;
|
EID: 0036333007
PISSN: 13648535
EISSN: None
Source Type: Journal
DOI: 10.1186/cc1529 Document Type: Article |
Times cited : (36)
|
References (18)
|